The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases. BP characteristically affects the elderly and is seen mainly in patients older than 70 years. While the annual incidence of BP has been estimated to be between 2.4 and 23 cases per million in the general pop...
Main Authors: | Khalaf Kridin, Ralf J. Ludwig |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00220/full |
Similar Items
-
Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid
by: Ágnes Kinyó, et al.
Published: (2021-04-01) -
Bullous Pemphigoid Induced by Vildagliptin
by: Bengür Taşkıran Bahattin, et al.
Published: (2016-12-01) -
Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran
by: Kamran Balighi, et al.
Published: (2018-11-01) -
Brunsting-Perry pemphigoid transitioning from previous bullous pemphigoid
by: Shengru Zhou, MD, PhD, et al.
Published: (2020-03-01) -
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
by: Kaisa Tasanen, et al.
Published: (2019-06-01)